BC
Balkrishna Chintamani Mishra
About Balkrishna Chintamani Mishra
Data last updated:
Balkrishna Chintamani Mishra has 4 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Myra Pharmaceuticals Private Limited. Formerly with 1 company, such as Fariox Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Myra Pharmaceuticals Private Limited U24230PN2022PTC209328 | Additional Director | 07 Jul 2022 | 2022 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Fariox Pharmaceuticals Private Limited U24290PN2022PTC217433 | Director | 30 Dec 2022 | 2022 | – | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Balkrishna Chintamani Mishra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Balkrishna Chintamani Mishra
Balkrishna Chintamani Mishra has 4 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Myra Pharmaceuticals Private Limited. Formerly with 1 company, such as Fariox Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Balkrishna Chintamani Mishra is associated with 1 company as Additional Director, including Myra Pharmaceuticals Private Limited.
Balkrishna Chintamani Mishra has expertise in General Business.
Balkrishna Chintamani Mishra has 4 years in corporate governance.
Balkrishna Chintamani Mishra currently holds positions at 1 company: Myra Pharmaceuticals Private Limited.